Download Aug.29(Fri)

52nd Annual Meeting of Japan Society of Clinical Oncology
Friday, August 29, 2014
Room 01 (Conference Center, 1F, Main Hall)
8:30 - 9:10
Keynote Lecture 03
KL3-1
Perspectives of cancer treatment targeting TGF-beta signaling
Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo
Room 01 (Conference Center, 1F, Main Hall)
Kohei Miyazono
9:10 - 11:10
Symposium 06
The Basic Plan to Promote Cancer Control Program
-Equalization or Centrilization of Medical Services to Further PromotionModerators: Keisuke Aiba (Clinical Oncology/Hematology, The Jikei University)
Masahiro Hiraoka (Radiation Oncology, Faculty of Medicine, Kyoto University)
S6-1
C
urrent and Future Health-Care Delivery System for Cancer Treatment Based On “Basic Plan
to Promote Cancer Control”
Cancer Control and Health Promotion Division, Health Policy Bureau,
Ministry of Health, Labour and Welfare
S6-2
S6-3
S6-4
S6-5
The next step of Designated Cancer Care Hospitals
National Cancer Center
How we should centralize the children with malignant diseases in Japan?
Department of Pediatrics, Graduate School of Medicine, Nagoya University
Future Prospective of National Clinical Database for Cancer Therapy
Department of Regenerative Surgery, Fukushima Medical University
Shuichiro Hayashi
Tomomitsu Hotta
Seiji Kojima
Mitsukazu Gotoh
C
urrent Status of Radiation Therapy in USA and the development of advanced Radiotherapy
Equipment
Division of Radiation Oncology, Department of Radiation Oncology,
The University of Texas MD Anderson Cancer Center, U.S.A.
Room 01 (Conference Center, 1F, Main Hall)
Ritsuko Komaki
11:10 - 12:00
Special Lecture 01
Moderator: Hisakazu Yamagishi (Kyoto Medical Support Center)
SL1-1
About the Mistery of Hokusai’s 36 Views of Mt. Fuji
Faculty of Culture and Information Science, Doshisha University
Room 01 (Conference Center, 1F, Main Hall)
Hiroyuki Kano
13:30 - 15:30
Symposium 07
Big-Data-Analysis Based Medicine in the Future
Moderators: Yoshiyuki Kakehi (Urology, Faculty of Medicine, Kagawa University)
Satoshi Morita (Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University)
S7-1
T he Future of Big Data Analytics in Japanese Public Health and Preventitive Care
Accenture Analytics, Digital Group, Accenture Japan Ltd.
Takuya Kudo
33
August 29
Moderator: Yoshihiko Maehara (Department of surgery and science, Graduate School, Kyushu University)
52nd Annual Meeting of Japan Society of Clinical Oncology
S7-2
S7-3
Innovation of Total Care Cycle by Utilizing Health Care related Bigdata
Health Care Company Health Care Business Division, Hitachi, Ltd.,
Atsushi Ugajin
A
bility of the Surgical Medical Treatment in Japan judging from the National Clinical
Database
Second Department of Surgery, Hamamatsu University School of Medicine
S7-4
S7-5
Hiroyuki Konno
C
ancer Care Through Big Data ASCO Cancer Linq
Camino, Hematology-Oncology, Palo Alto Medical Foundation, U.S.A.
Peter P. Yu
p
romotion of the utilization of the health insurance claims, specific health checkups and
specific counseling guidance database in Japan
August 29
Office for Health Insurance System Enhancement, Health Insurance Bureau,
Ministry of Health, Labour and Welfare
Atsushi Sakuma
Room 01 (Conference Center, 1F, Main Hall)
15:30 - 17:30
Organ Specific Symposium 09
Recent Progress in Palliative Medicine - First Contact to the End of Life Care Moderators: Etsuko Aruga (Dept. of Palliative Medicine, School of Medicine, Teikyo University)
Yasuo Shima (Palliatve Medicine, Tsukuba Medical Center Hospital)
OS9-1 What is “early palliative care”?
Department of Medical Oncology, Toranomon Hospital
Toshimi Takano
OS9-2 E
fficacy of the percutaneous trans-esophageal gastro-tubing (PTEG) drainage for
gastrointestinal obstruction due to carcinomatosis
Division of Gastroenterological Surgery, Department of Surgery, Yachiyo Medical Center,
Tokyo Women’s Medical University
Hideto Oishi
OS9-3 New therapeutic approaches for breakthrough cancer pain
Division of Palliative Medicine, Shizuoka Cancer Center Hospital
Iwao Osaka
OS9-4 T
he Development of the End-of-Life Nursing Education Consortium-Japan and Challenges
related to Nursing Education
Department of Human Health Science, Graduate School of Medicine, Kyoto University
Keiko Tamura
OS9-5 T
he development and clinical application of Liverpool Care Pathway Japanese Version in
end of life care
Department of Palliative Care, Toshiba General Hospital
Room 02 (Conference Center, 3F, 301+302)
Yoshikazu Chinone
9:10 - 11:10
Organ Specific Symposium 10
Up-to-Date Colorectal Cancer Treatment
Moderators: Tetsuji Takayama (Institutes of Health Bioschience, Institute of Health Biosciences, Graduate School, The University of Tokushima)
Masaki Mori (Department of Surgery, Graduate School of Medicine, Osaka University)
OS10-1 Molecularly targeting therapy for colorectal cancer
Gastrointestinal Cancer Center, Medical Oncology, Dana-Farber Cancer Institute, U.S.A.
Jeffrey A. Meyerhardt
OS10-2 Strategy for liver metastasis from colorectal cancer: medical treatment
Department of Gastroenterology and Gastrointestional Oncology,
National Cancer Center Hospital East Kohei Shitara
OS10-3 The treatment strategy on the basis of clinical outcome of colorectal cancer with
synchronous liver metastasis
Department of Organ Regulatory Surgery, School of Medicine, Fukushima Medical University
Kensuke Kumamoto
OS10-4 Treatment strategy for pulmonary metastases from colorectal carcinoma -Progression of
chemotherapy and significance of surgical interventionDepartment of General Thoracic Surgery, Graduate School of Medicine, Osaka University
34
Masayoshi Inoue
52nd Annual Meeting of Japan Society of Clinical Oncology
OS10-5 Treatment for metastatic brain tumor of colon cancer patients
General Medical Education Center, Faculty of Medicine, Yamagata University
Shinya Sato
Room 02 (Conference Center, 3F, 301+302)
13:30 - 15:30
Moderators: Shunichi Yamashita (Nagasaki University)
Ohtsura Niwa (Fukushima Medical University)
ASJS-1
R
adiation Health Challenges for Deep Space Human Missions and Relevance to Concerns
here on Earth
Space Biosciences Division, NASA Ames Research Center, U.S.A.
ASJS-2
Tore Straume
I ssues in Low Dose Radiation Effects on Human Health, Cancer and Non-Cancer Related
Effects
Biological Sciences Division, Radiation Biology and Biophysics,
Pacific Northwest National Laboratory (PNNL), U.S.A.
ASJS-3
ASJS-4
ASJS-5
William F. Morgan
Low Dose Radiation Risk and the New Radiobiology
Center for Radiological Research, Department of Radiation Oncology,
Columbia University Medical Center, U.S.A.
Tom K. Hei
New Perspectives on Radiation Carcinogenesis and Breast Cancer
Department of Radiation Oncology and Cell Biology,
New York University School of Medicine, U.S.A.
Mary Helen Barcellos-Hoff
D
NA damage and tissue reaction in tissues/organs exposed to low-dose and low-dose-rate
radiation in mice
Atomic Bomb Disease Institute, Nagasaki University
Keiji Suzuki
Room 02 (Conference Center, 3F, 301+302)
15:30 - 17:30
Symposium 08
Development of Caner Diagnosis
Moderators: Yasuhiro Matsumura (Rsearch Center for Innovative Oncology, National Cancer Center Hospital East)
Yoshiyuki Suzuki (Department of Radiology, Fukushima Medical University)
S8-1
Metabolomics and its applications to medicine
S8-2
S8-3
S8-4
S8-5
S8-6Diffusion-weighted whole-body imaging with background body signal suppression
(DWIBS): features and potential applications in oncology
Institute for Advanced Biosciences, Keio University
Real-time detection of cancer spread with ultrafast automated image cytometry
Department of Chemistry, Graduate School of Science, The University of Tokyo
S8-7
Keisuke Goda
D
etection and analysis of circulating nucleotide by using bio-chip for early cancer diagnosis
Digestive Disease Center, Koto-Toyosu Hospital, Showa University
Hiroaki Ito
Development for high-sensitive diagnosis based on refracted X-ray detection
Institute of Multidisciplinary Research for Advanced Materials, Tohoku University
Quantitative tissue characterization using very high frequency ultrasound
Center for Frontier Medical Engineering, Chiba University
Dept. of Biomedical Engineering, School of Engineering, Tokai University
Masaru Tomita
Cancer Diagnosis using PET/MRI
Molecular Imaging Center, National Institute of Radiological Sciences
Atsushi Momose
Tadashi Yamaguchi
Taro Takahara
Hiroshi Ito
35
August 29
ASCO/JSCO Joint Symposium
Low Dose Radiation Effects on Human Health, Especially Radiation-induced
Carcinogenesis
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 03 (Conference Center, 3F, 303+304)
9:10 - 11:10
Organ Specific Symposium 11
Up-to-Date Breast Cancer Treatment
- Future Prospective of Endocrine Resistant Breast Cancer Moderators: Toshiaki Saeki (Breast Oncology, International Medical Center, Saitama Medical University)
Jun Horiguchi (Breast and Endocrine Surgey, Faculty of Medicine, Gunma University)
OS11-1 Mechanisms of endocrine therapy-resistance
August 29
Deparment of Molecular and Functional Dynamics, Graduate School of Medicine,
Tohoku University
Shin-Ichi Hayashi
OS11-2 Overcoming resistance to endocrine therapy in breast cancer by the wisdom from
translational research
Target Therapy Oncology, Graduate School of Medicine, Kyoto University
OS11-3 Novel therapeutic strategies of endocrine resistance in breast cancer
Department of Surgery, School of Medicine, Fukushima Medical University
Shigehira Saji
Tohru Ohtake
OS11-4 To reverse resistance to endocrine therapy -the combination of targeted drugs with
endocrine therapy
Breast Surgery, Hospital, Hokkaido University
Hiroko Yamashita
OS11-5 Future Perspectives of endocrine therapy for breast cancer in neoadjuvant, adjuvant and
metastatic setting
Dept of Breast and Endocrine Surgery, Faculty of Life Sciences, Kumamoto University
Room 03 (Conference Center, 3F, 303+304)
Hirotaka Iwase
13:30 - 15:45
Symposium 09
Support for Cancer Survivor to Return to Work, during or after Treatment
-How to Enhance Communication from Hospital to Work Place StaffsModerators: Hiroshi Shimada (Japan labour Health & Welfare Organization / Harue Hospital)
Toru Sugiyama (School of Medicine, Iwate Medical University)
S9-1
S9-2
S9-3
Social innovation for cancer patients to work with their rights
The Cancer Institute Hospital
Achieve a good balance between labor’s medical treatment and a job
Industrial Health Office, Ministry of Health, Labour and Welfare
S9-4
S9-5
S9-6
S9-7
S9-8
36
Makoto Matsuzaki
F
acilitated peer support in breast cancer patients; towards mental health care and social
rehabilitation
Patient & Family Support Center, yokohama Rosai Hospital
Morito Monden
From a standpoint of a psychiatrist
Psyho-Oncology, National Cancer Center Hospital
Collaboration with Cancer treatment and occupational health
Health Care Center, NEC Corporation
Tomoko Yagi
Ken Shimizu
Ayumu Kakinuma
S
upport for employment of cancer survivors from the viewpoint of cancer sociology
Shizuoka Cancer Center
Problem in worker affected by cancer-present and future
Tokyo Rhosai Hospital, Japan Labour Health and Welfare Organization
Work and cancer survivors - what can doctors and nurses do?
Center for Cancer Control and Information Services, National Cancer Center
Ken Yamaguchi
Shigeru Kadoyama
Miyako Takahashi
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 06 (Conference Center, 3F, 315)
9:10 - 11:10
International Symposium 03 (Princess Takamatsu Cancer Research Fund Sponsored)
The Future of Cancer Therapy
-Novel Strategies for Cancer Control based on Genetic / Epigenetic InformationModerators: Jun Yokota (Genomics and Epigenomics of Cancer Prediction Program,
Institute of Predictive and Personalized Medicine of Cancer (IMPPC))
Aiko Okamoto (Department of Obstetris and Gynecology, The Jikei University)
TIS3-1 Molecular profiling of myelodysplastic syndromes
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University
Seishi Ogawa
TIS3-2 E
merging Opportunities and Challenges for Targeted Therapy in Human Lung Cancers
Department of Medical Oncology, Dana-Farber Cancer Institute, U.S.A.
Angela N. Brooks
TIS3-3 R
ET fusion gene and chromatin remodeling genes: personalized therapy of lung cancer
Division of Genome Biology, National Cancer Center Research Institute
Takashi Kohno
TIS3-4 Cancer Epigenetics: From Knowledge to Applications
Cancer Epigenetics and Biology Program(PEBC),
Bellvitge Biomedical Research Institute(IDIBELL), Spain Manel B. Esteller
TIS3-5 I nterweaving the Threads of the p53, MicroRNA, and Inflammation Networks into the
Tapestry of Aging and Cancer
National Institutes of Health, National Cancer Institute Molecular Genetics and Carcinogenesis Section
Research Center for Cancer Research,U.S.A.
Room 06 (Conference Center, 3F, 315)
Curtis C. Harris
13:30 - 15:30
International Symposium 04 (Princess Takamatsu Cancer Research Fund Sponsored)
The Future of Cancer Therapy
-Translational Approaches Targeting for Anti-cancer TherapyModerators: Ryuzo Ueda (Department of Tumor Immunology, School of Medicine, Aichi Medical University)
Toshiyoshi Fujiwara (Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences, Okayama University)
TIS4-1 D
evelopment of monoclonal antibody (Mogamulizumab) as a drug for ATL patients
Department of Tumor Immunology, School of Medicine, Aichi Medical University
Ryuzo Ueda
TIS4-2 R
ecent Advances in The Strategy for Clinical Research in Childhood Cancer in Japan (JCCG)
Dept. of Pediatrics, Tokyo Medical and Dental University
Shuki Mizutani
TIS4-3 A
n Accelerated Comprehensive Strategy to Fight Triple-Negative Breast Cancer Under the
Moon Shots Program
Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas,
MD Anderson Cancer Center, U.S.A.
Naoto T. Ueno
TIS4-4 T
he Future of Cancer Therapy: Translational Approaches To Targeting For Anti-cancer
Therapy
Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis,
NIH/NCI, U.S.A.
TIS4-5 Current Actions of PMDA for New Drug Development of Japan Origin
Director of Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency (PMDA)
Naoko Takebe
Takao Yamori
37
August 29
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 06 (Conference Center, 3F, 315)
15:30 - 17:30
International Symposium 05 (Princess Takamatsu Cancer Research Fund Sponsored)
The Future of Cancer Therapy
-Expansion of Radionuclide Therapy in JapanModerators: Makoto Hosono (Institute of Advanced Clinical Medicine, Faculty of Medicine, Kinki University)
Shunichi Yamashita (Nagasaki University)
TIS5-1 Thyroid Cancer and Radioactive Iodine Therapy
University Hospital of Wuerzburg, Germany
Christoph Reiners
August 29
TIS5-2 P
eptide Receptor Radionuclide Therapy (PRRT) for the treatment of patients with
neuroendocrine tumors
Department of Radiology & Nuclear Medicine, University of Basel Hospital, Switzerland
TIS5-3 Cellular/molecular targeting in radionuclide therapy
Molecular Imaging Center, National Institute of Radiological Sciences
Damian Wild
Yasuhisa Fujibayashi
TIS5-4 Radium-223 in Castrate-Resistant Prostate Cancer
Department of Medicine and Urology, Tulane School of Medicine, Tulane Cancer Center, U.S.A.
Oliver Sartor
Room 10 (Conference Center, 4F, 418)
8:20 - 10:00
FACO Symposium
Approaches to the First Clinical Trial
Moderators: Yi-Long Wu (Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences)
Hyun-Choel Chung (Department of Medical Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System)
Masahiko Nishiyama (Department of Molecular Pharmacology and Oncology, Graduate School of Medicine, Gunma University)
FS-1
S
ignificance of conducting gastric cancer clinical study and possible international clinical
trials of FACO as the first challenge
Department of Surgical Oncology, Gifu University
FS-2
FS-3
FS-4
Current development of advanced gastric cancer research in China
Medical Oncology Dept., Sir Run Run Shaw Hospital, Zhejiang University, China
Kazuhiro Yoshida
Hong-Ming Pan
Current challenges and developing platform of gastric cancer research in Korea
Department of Medical Oncology, Internal Medicine,
Yonsei Cancer Center, Yonsei University College of Medicine, Korea Academic Committee and support system for FACO clinical research
Surgery, School of Medicine, Keio University
Room 10 (Conference Center, 4F, 418)
Sun Young Rha
Yuko Kitagawa
10:00 - 12:00
ESMO/JSCO Joint Symposium
Biomarkers of Common Cancers for the Personalized Medicine Breast / Colorectal / Lung
Moderators: Chikashi Ishioka (Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University)
Fortunato Ciardiello (Department of Experimental and Clinical Medicine and Surgery, The Second University of Naples)
ESJS-1
ESJS-2
A
new era of genotype-based targeted therapies for advanced non-small-cell lung cancer
Center for Clinical and Translational Research, Hospital, Kyushu University
P
erspective of the development of genome biomarker-based precision medicine of
colorectal cancer
Division of Translational Research Exploratory Oncology and Clinical Trial Center,
National Cancer Center
38
Isamu Okamoto
Katsuya Tsuchihara
52nd Annual Meeting of Japan Society of Clinical Oncology
ESJS-3
Use of predictive biomarkers for molecular targeted therapies in Europe
Division of Medical Oncology, Department of Experimental and Clinical Medicine and Surgery,
The Second University of Naples, Italy
The landscape of genomic alterations
Breast Cancer Translational Research Laboratory - BCTL, Institut Jules Bordet,
Université Libre de Bruxelles, Belgium
Christos Sotiriou
Room 10 (Conference Center, 4F, 418)
14:30 - 17:30
Special Seminar
Climbing The Way: the World Standards for Success (Promoted by UJA)
Part 1: President Lectures
14:30 - 15:00
Keynote Lecture 04〈ECCO Board Member〉
Moderator: Masaki Kitajima (President and Professor, International University of Health and Welfare)
KL4-1
An European perspective on surgical oncology and improved cancer care
Surgery, Sahlgrenska University Hospital, Sweden
Peter Naredi
15:00 - 15:30
Keynote Lecture 05〈ESMO President-elect〉
Moderator: Norio Nonomura (Department of Urology, Faculty of Medicine, Osaka University)
KL5-1
TBD
Department of Experimental and Clinical Medicine and Surgery,
The Second University of Naples, Italy
Fortunato Ciardiello
15:30 - 16:00
Keynote Lecture 06〈ASCO President〉
Moderator: Ikuo Konishi (Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University)
KL6-1
Meeting the Challenge of Oncology Global Health
Hematology-Oncology, Palo Alto Medical Foundation, U.S.A.
Peter P. Yu
Part 2: Career Development Seminar
Moderators: Masaya Baba (International Research Center for Medical Sciences (IRCMS), Priority Organization for Innovation
and Excellence, Kumamoto University / ex National Institutes of Health, National Cancer Institute,
Center for Cancer Research, Urologic Oncology Branch, U.S.A.)
Kohei Homma (Department of Physiology, Nippon Medical School / ex National Institutes of Health,
Atsuo Sasaki (University of Cincinnati Cancer Institute, Cincinnati Cancer Center, U.S.A. )
Speakers: University of Cincinnati Cancer Institute, Cincinnati Cancer Center, U.S.A.
National Eye Institute, Neurobiology Neurodegeneration & Repair Laboratory (N-NRL), U.S.A.)
Division of Cancer Medicine, Department of Breast Medical Oncology,
The University of Texas, MD Anderson Cancer Center, U.S.A.
Cancer Therapy Evaluation Program(CTEP),
Division of Cancer Treatment and Diagnosis,
National Institutes of Health, National Cancer Institute, U.S.A.
Atsuo Sasaki
Naoto Ueno
Naoko Takebe
39
August 29
ESJS-4
Fortunato Ciardiello
52nd Annual Meeting of Japan Society of Clinical Oncology
Part 3: Panel Discussion
Pnanelists: ASCO President;
Hematology-Oncology, Palo Alto Medical Foundation, U.S.A.
ECCO Board of Directors;
Surgery, Sahlgrenska University Hospital, Sweden
ESMO President-elect;
Department of Experimental and Clinical Medicine and Surgery,
The Second University of Naples, Italy
August 29
Peter P. Yu
Peter Naredi
Fortunato Ciardiello
University of Cincinnati Cancer Institute, Cincinnati Cancer Center, U.S.A.
Atsuo Sasaki
Division of Cancer Medicine, Department of Breast Medical Oncology,
The University of Texas, MD Anderson Cancer Center, U.S.A.
Cancer Therapy Evaluation Program(CTEP),
Division of Cancer Treatment and Diagnosis,
National Institutes of Health, National Cancer Institute, U.S.A.
Naoto Ueno
Naoko Takebe
Commentator: Senior Director, International Affairs of ASCO, U.S.A.
Doug Pyle
Room 12 (Conference Center, 5F, 501)
9:10 - 11:10
Symposium 10
Therapeutic Feature and Fertility Issue in Treatment for Young Cancer Patients
Moderators: Daisuke Aoki (Department of Obstetrics & Gynecology, School of Medicine, Keio University)
Yoichi Arai (Department of Urology, Graduate School of Medicine, Tohoku University)
S10-1
S10-2
S10-3
S10-4
S10-5
S10-6
Current topics and problems on oncofertility for the young cancer patients
Department of Obstetrics and Gynecology, School of Medicine, St. Marianna University
Fertility issues in breast cancer patients
Breast and Medical Oncology Division, National Cancer Center Hospital
Nao Suzuki
Chikako Shimizu
Current strategies to preserve fertility in patients with hematological disorders
Division of Hematology, Saitama Medical Center, Jichi Medical University
Gonadal function and fertility of childhood cancer survivors
Department of Pediatrics, Graduate School of Medicine, Osaka University
Fertility preservation in urological malignancies
Department of Urology, Koshigaya Hospital, Dokkyo Medical University
Yoshinobu Kanda
Yoko Miyoshi
Hiroshi Okada
ASCO Guidelines for Fetility Preservation:2013 Update
Cell Biology & Anatomy, Medicine and Pathology, Division of Reproductive Medicine & Innovation,
Institute for Fertility Preservation, Obstetrics & Gynecology, New York Medical College, U.S.A.
Room 12 (Conference Center, 5F, 501)
Kutluk H. Oktay
13:30 - 14:00
Keynote Lecture 07
Moderator: Takashi Nakano (Graduate School of Medicine, Gunma University)
KL7-1
U
ltra-High Field MRI and Its Clinical Applications : In Vivo Human Imaging with Highest
Resolution & Sensitivity
Gachon Univ. of Medicine & Science, Neuroscience Research Institute, Korea
40
Zang-Hee Cho
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 12 (Conference Center, 5F, 501)
14:10 - 16:10
Organ Specific Symposium 12
Up-to-Date Brain and Bone Metastasis Treatment
Moderators: Junichi Kuratsu (Dept of Neurosurgery, Faculty of Life Sciences, Kumamoto University)
Yukihide Iwamoto (Orthopaedics, Graduate School of Medical Sciences, Kyushu University)
OS12-1 Medicinal treatment of bone metastasis; from the clinical oncologists’ point of view
Hiroyuki Shibata
OS12-2 Treatment of Bone Metastatic Disease: Paradigm shifting with Radium-223
Depts of Medicine and Urology, Tulane School of Medicine, Tulane Cancer Center, U.S.A.
Oliver Sartor
OS12-3 Surgical strategy for bone metastasis; the result of questionaires to JCOG-BSTTSG member
Dept. of Orthop. Surg., Osaka Medical Center for Cancer and Cardiovascular Diseases
OS12-4 Brain metastasis : a perspective from medical oncologists
Division of Medical Oncology, Cancer Research Institute, Kanazawa University
Nobuhito Araki
Seiji Yano
OS12-5 The role of radiotherapy in the management of brain metastasis: strategies for long-term
efficacy and safety
Radiation Oncology, Faculty of Life Sciences, Kumamoto University
OS12-6 Metastatic brain tumours: Surgical management and techniques
Division of Neurosurgery, Shizuoka Cancer Center
Room 13 (Conference Center, 5F, 502)
Natsuo Oya
Yoko Nakasu
9:10 - 11:20
Organ Specific Symposium 13
Up-to-Date Pediatric Cancer Treatment
-How Do We Treat Adolescents and Young Adults (AYA) with Cancer?Moderators: Hajime Hosoi (Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)
Hiroyuki Tsuchiya (Orthopaedic, Graduate School of Medical Science, Kanazawa University)
OS13-1 Policy for Treatment of “Pediatric Cancers” occurring in Adolescents and Young Adults
Department of Pediatrics, Graduate School of Medical Science,
Kyoto Prefectural University of Medicine
Hajime Hosoi
OS13-2 Current status of pediatric solid malignant tumor~Past, Present and Future as a core
hospital in Kyushu area~
Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University
OS13-3 Surgical treatment for soft tissue sarcomas of the AYA ages
Musculoskeletal Oncology, National Cancer Center Hospital
OS13-4 Progress of limb-saving surgery for osteosarcoma
Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University
Tomoaki Taguchi
Akira Kawai
Hiroyuki Tsuchiya
OS13-5 A New Therapeutic Era for Soft Tissue Sarcoma; Cooperative Treatment with Horizontal
Specification and Molecular Targeted Therapy with Pazopanib, A Multikinase Inhibitor with
Antiangiogenesis Activity
Department of Molecular Medicine & Pathophysiology,
Osaka Medical Center for Cancer and Cardiovascular Diseases Katsuhito Takahashi
OS13-6 Current state and challenges of treatment of AYA generation patients with hematological
malignancies in Japan
Department of Hematology / Oncology, Saitama Children’s Medical Center
Katsuyoshi Koh
41
August 29
Dept. Clinical Oncology, Akita University
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 13 (Conference Center, 5F, 502)
13:30 - 14:30
Video Panel Discussion 01
The Cutting Edge of Robotic Surgery Inspiration from other Field (Head and Neck)
Moderators: Seiji Kishimoto (Head and Neck Surgery, Kameda Medical Center)
Hirokazu Noshiro (Surgery, Saga University Hospital)
VPD1-1
VPD1-2
August 29
VPD1-3
Robotic surgery in Otolaryngology Head and neck surgery
Otolaryngology, Tokyo Medical University
Hiroyuki Ito
Robot- assisted esophagectomy for esophageal carcinoma
Surgery, Fujita Health University
Ichiro Uyama
Robotic surgery for mediastinal disease
Division of General Thoracic Surgery, Department of Surgery, Faculty of Medicine,
Tottori University
Hiroshige Nakamura
Room 13 (Conference Center, 5F, 502)
14:30 - 15:30
Video Panel Discussion 02
The Cutting Edge of Robotic Surgery Inspiration from other Field (Pelvic Surgery)
Moderators: Toshiro Terachi (Department of Urology, Faculty of Medicine, Tokai University)
Masahiko Watanabe (Surgery, School of Medicine, Kitazato University)
VPD2-1
VPD2-2
Robotic rectal cancer surgery
Colon and Rctal Surgery, Shizuoka Cancer Center
R
obot -Assisted Radical Prostatectomy -Intraoperative Techniques to Improve Surgical
Outcome-
Department of Urology, School of Medicine, Fukushima Medical University
VPD2-3
Yusuke Kinugasa
Yoshiyuki Kojima
Robot-assisted surgery for uterine cancer
Department of Obstetrics and Gynecology, Tokyo Medical University
Keiichi Isaka
Room 14 (Conference Center, 5F, 503)
9:10 - 11:10
Organ Specific Symposium 14
Up-to-Date Esophageal Cancer Treatment
Moderators: Hiroyuki Kato (First Department of Surgery, Dokkyo Medical University)
Kenji Nemoto (Department of Radiation Oncology, Faculty of Medicine, Yamagata University)
OS14-1 The strategy of esophageal stricture after ESD for superficial esophageal squamous cell
carcinoma
Department f Endoscopy, Nagasaki University Hospital
Naoyuki Yamaguchi
OS14-2 Minimally invasive open-esophagectomy with 3-field lymph node dissection for esophageal
cancer
Department of Frontier Surgery, Graduate School of Medicine, Chiba University
Yasunori Akutsu
OS14-3 Selection of the treatments for advanced esophageal cancer and adjuvant therapies
Department of Surgery 1, Dokkyo Medical University
Masanobu Nakajima
OS14-4 Salvage surgery after definitive chemoradiotherapy for thoracic esophageal cancer
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University
Hiroshi Miyata
OS14-5 The role of proton beam therapy in concurrent chemoradiotherapy for esophageal cancer
Radiation Oncology, Hospital, Tsukuba University
OS14-6 Current perspective of oncological trial for esophageal squamous carcinoma
Division of Gastroenterology, School of Medicine, Keio University
42
Hitoshi Ishikawa
Yasuo Hamamoto
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 14 (Conference Center, 5F, 503)
15:30 - 17:30
Organ Specific Symposium 15
Up-to-Date Multimodal Therapy for Urologic Cancer
Moderators: Hirotsugu Uemura (Department of Urology, Faculty of Medicine, Kinki University)
Yoshihiko Tomita (Department of Urology, Faculty of Medicine, Yamagata University)
OS15-1 Developing the next-generation of targeted therapies for castration resistant prostate
cancer (CRPC)
Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers,
Memorial Sloan-Kettering Cancer Center, U.S.A.
Department of REnal-Genitourinary Surgery, Graduate School of Medicine, Hokkaido University
OS15-3 Multidisciplinary treatment for metastatic advanced renal cell carcinoma
Department of Urology, Faculty of Medicine, Kinki University
OS15-4 Multidisciplinary Therapy for Advanced Prostate Cancer
Department of Urology, Tokyo KoseiNenkin Hospital
Room 15 (National Convention Hall of Yokohama)
Nobuo Shinohara
Kazuhiro Yoshimura
Koichiro Akakura
8:00 - 10:00
Team Medicine in Personalized Treatment 3
Psycho-social Aspects of Cancer Medicine
Moderators: Yosuke Uchitomi (Neuropsychiatry, Graduate School of Medicine,Dentistry and Pharmaceutical Sciences, Okayama University)
Eisuke Matsushima (Section of Laison Psychiatry and Palliative Medicine , Tokyo Medical and Dental University)
ST3-1 Social and psychological problems in patients with cancer
Section of Laison Psychiatry and Palliative Medicine , Tokyo Medical and Dental University
ST3-2 The role of psychologists in cancer care
Psycho-Oncology Division / Patient Support Center, Gunma Prefectural Cancer Center
Eisuke Matsushima
Akira Oba
ST3-3 Role of Psychologists/Psychotherapists in the Interdisciplinary Team
Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center
Komagome Hospital
ST3-4 Total care for the children with cancer
Department of Pediatric Oncology, National Cancer Center Hospital
Yukie Kurihara
Chitose Ogawa
ST3-5 Care and Support for the Families of Cancer Patients
Medical Support and Partnership Division, Center for Cancer Control and Information Services,
National Cancer Center Room 15 (National Convention Hall of Yokohama)
Masashi Kato
10:00 - 12:00
Team Medicine in Personalized Treatment 4
In Terms of Cancer Rehabilitation
Moderators: Masashi Kato (Medical Support and Partnership Division, National Cancer Center, Center for Cancer Control and Information Service)
Tetsuya Tsuji (Department of Rehabillitation Medicine, School of Medicine, Keio University)
ST4-1 Cancer treatment related problems and rehabilitation
Department of Rehabilitation Medicine, Kameda Medical Center
ST4-2 Prospects of Cancer Rehabilitation
School of Physical Therapy, Faculty of Health and Medical Care, Saitama Medical University
ST4-3 The role of Occupatinal Therapist in cancer rehabilitation
Division of Rehabilitation Medicine, Shizuoka Cancer Center
Koichi Miyakoshi
Yasuyuki Takakura
Hisako Tajiri
43
August 29
OS15-2 Multimodal therapy for advanced bladder cancer
Howard I. Scher
52nd Annual Meeting of Japan Society of Clinical Oncology
ST4-4 The role of speech-language-hearing therapist in cancer rehabilitation
Department of Rehabilitation Medicine, Hospital, Keio University
Makiko Ando
ST4-5 The request from a support group
Lymphedema Support Group ASUNARO-KAI
Atsuko Higashi
Room 15 (National Convention Hall of Yokohama)
13:30 - 15:30
August 29
Team Medicine in Personalized Treatment 5
Communication for Personalized Treatment
Moderators: Junichi Sakamoto (Tokai Central Hospital)
Tsuneharu Miki (Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)
ST5-1 Current status of medical network navigator system in Japan
Clinical Oncology/Hematology, The Jikei University
ST5-2 Support as the site clinical data manager
Clinical Research Center, Saku Central Hospital
ST5-3 Medical decision making support
Rakkan Nurse Inc
ST5-4 Use of EDC in clinical trial
Data management / Biostatistics, SRD Co. Ltd.
Keisuke Aiba
Miyuki Niimi
Yuri Iwamoto
Akira Sugihara
ST5-5 New role of data manager in order to respond to the individualization of clinical trials
Data Center, Aichi branch, Epidemiological and Clinical Research Information Network
Room 15 (National Convention Hall of Yokohama)
Yumi Miyashita
15:30 - 17:30
Team Medicine in Personalized Treatment 6
Role of Nutritional Support
Moderators: Masaaki Oka (Department of Digestive Surgery and Surgical Oncology, Graduate School of Medicine, Yamaguchi University)
Hiromitsu Takeyama (Gastroenterological Surgery, Nagoya City University)
ST6-1 Dysphagia rehabilitation and oral care in cancer treatment
Department of Dentistry, School of Medicine, Fujita Health University
Koichiro Matsuo
ST6-2 Diet and nutrition in patients with anti-cancer therapy -from a viewpoint of the expertHospital, Shimane University
Mikiko Kawaguchi
ST6-3 Training of oncoogy dietitian specialist by Cancer Professional Educaition Consortium
Department of Nutrition and Metabolism, Graduate School of Medicine,
The University of Tokushima
Yutaka Nakaya
ST6-4 Significance of metabolic and nutritional support for cancer patients under anti-cancer
therapy
Department of COmprehensive Life Sciences, Wayo Women’s University Graduate School
Yoichi Sakurai
ST6-5 Significance of nutritional management by NST in cancer patients: for more contribution by
medical staff professionally trained
NST, Chiba Cancer Center
ST6-6 Nutrition Support in Palliative Medicine
Yoshihiro Nabeya
Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University Takashi Higashiguchi
44
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 16 (Annex Hall, 2F, F201)
13:30 - 15:30
Symposium 11
New Movement to Overcome Immune Escape Mechanisms
Moderators: Masahiro Shibata (International Medical Center, Saitama Medical University)
Mamoru Harada (Department of Immunology, Fuculty of Medicine, Shimane University)
I mmune suppression relating myeloid-derived suppressor cells and systemic inflammation,
and its regulation
International Medical Center, Saitama Medical University
S11-2
S
tratagems to regulate the immune-escape mechanism of cancers at the vaccine treatment
of epitope-peptides for cancer, and perspective for cancer vaccine therapy
Department of Digestive Surgery and Surgical Oncology, Graduate School of Medicine,
Yamaguchi University
S11-3
S11-5
Shoichi Hazama
M
itigation of immunosuppression and the induction of antitumor T cell response by anticancer drugs or BRM
Department of Immunology, Fuculty of Medicine, Shimane University
S11-4
Masahiko Shibata
Mamoru Harada
M
ogamulizumab as anti-Tregs agent
Department of Medical Oncology and Immunology, Graduate School of Medical Sciences,
Nagoya City University
Takashi Ishida
C
linical application of humanized anti-CD4 antibody for the treatment of solid tumors
Department of Molecular Preventive Medicine, Graduate School of Medicine,
The University of Tokyo
Room 17 (Annex Hall, 2F, F202)
Kouji Matsushima
8:00 - 10:00
Organ Specific Symposium 16
Up-to-Date Multiple Myeloma Treatment
Moderators: Yoshihiro Torimoto (Oncology Center, Asahikawa Medical University Hospital)
Mitsune Tanimoto (Hematology & Oncology, Graduate School of Medicine,Dentistry and Pharmaceutical Sciences,
Okayama University)
OS16-1 Molecular basis of pharmacotherapy for multiple myeloma
Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University
Yusuke Furukawa
OS16-2 Current treatment strategy for patients with untreated symptomatic myeloma who are
eligible for stem cell transplantation
Division of Hematology, Saitama Medical Center, Jichi Medical University
Yoshinobu Kanda
OS16-3 Current approaches of the treatment for the transplant-ineligible patients with newly
diagnosed multiple myeloma
Department of Hematoogy, Saitama Medical Center, Saitama Medical University
Michihide Tokuhira
OS16-4 Consolidation and maintenance therapy for multiple myeloma
Department of Hematology, Japan Community Health care Organization
Kyoto-Kuramaguchi Medical Center OS16-5 Treatment for relapsed/refractory multiple myeloma
Department of Hematology, National Hospital Organization Okayama Medical Center
Chihiro Shimazaki
Kazutaka Sunami
OS16-6 Clinical development of novel agents in multiple myeloma
Department of Medical Oncology & Immunology, Graduate School of Medical Sciences,
Nagoya City University
Shinsuke Iida
45
August 29
S11-1
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 17 (Annex Hall, 2F, F202)
10:00 - 12:00
Symposium 12
Perspectives on Lifestyle Risk Factors for Gastroenterological Cancers
Moderators: Yuichiro Doki (Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University)
Shoji Natsugoe (Digestive Surgery and Breast and Thyroid Surgery, Faculty of Medicine, Kagoshima University)
S12-1
F
ield cancerization phenomenon in the head and neck region and esophagus and its
relation to alcohol metabolizing enzyme
Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University
August 29
S12-2
Manabu Muto
T
he Epidemiology of gastric cancer: the relationship of H.pylori infection and diabetes with
risk of gastric cancer
Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University
S12-3
S12-4
S12-5
Chemoprevention of Colon Cancer
Graduate Program in Environmental Health Sciences, University of Shizuoka
Fumie Ikeda
Keiji Wakabayashi
O
besity, life style-related diseases and biliary tract diseases (gallstone, biliary tract cancer)
Gastroenterology, Graduate School of Comprehensive Human Sciences, University of Tsukuba
Junichi Shoda
A
genome-cohort study for personalized GI tract cancer prevention in the Japanese
population
Division of Epidemiology and Prevention, Aichi Cancer Center Research Insitute
Room 19 (Annex Hall, 2F, F205+F206)
Hideo Tanaka
8:00 - 10:00
Panel Discussion 02
Changes of Health Care Systems in Japan by Task Shifting from Physicians to Registered
Nurses in the Future
Moderators: Tohru Aruga (Department of Emergency & Critical Care Medicine, School of Medicine, Showa University)
Tomoko Kusama (Tokyo Healthcare University)
PD2-1 W
ith the aim of regional development of training system for nurses that support the Cnacer
treatment
Hoshi General Hospital Foundation
PD2-2 Paradigm shift of cancer chemotherapy in outpatient : docter’s perspective
Division of Medical Oncology, School of Medicine, Showa University
PD2-3 Expectation of expanding of role of nurses in team medicine
Faculty of Nursing Science, Tokyo Healthcare University
Hokuto Hoshi
Yasutsuna Sasaki
Tomoko Kusama
PD2-4
From Team-based Medicine to Organizational Medicine; Efficiency of Services, Flexible
Organization, and Revision of Job Demarcations among Professional Licencies
Graduate School of Business Administration, Keio University
PD2-5 An opinion from a nurse who worked as a nurse practitioner in New York
School of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo
Takeshi Oyabu
Miho Suzuki
PD2-6What are patients looking for?: Expectations for the system of “Japanese Nurse Practitioner”
Health and Medical News Department, Editorial Bureau, The Yomiuri Shimbun Tokyo Head Office
46
Naoko Iwanaga
52nd Annual Meeting of Japan Society of Clinical Oncology
Room 19 (Annex Hall, 2F, F205+F206)
10:00 - 12:00
Panel Discussion 03
The Current Situation and Issues of Terminal Care as a Matter of Society
(Japanese Society for Palliative Medicine Sponsored)
Moderators: Toyoshi Hosokawa (Department of Pain Management & Palliative Care Medicine, Kyoto Prefectural University of Medicine)
Takashi Higashiguchi (Department of Surgery & Palliative Medicine, Fujita Health University School of Medicine)
End-of-life Care Team, National Center for Geriatrics and Gerontology
Mitsunori Nishikawa
PD3-2 Possible Impacts of the Trans-Pacific Partnership on End-of-life Care
Department of Health Policy Science, Graduate School of Medical Sciencies,
Yamagata University
Masayasu Murakami
PD3-3 T
he Japan Geriatrics Society’s Guidelines for decision-making process of artificial hydration
and nutrition for older adults
Center for Death & Life Studies and Practical Ethics, Uehiro Division,
Graduate School of Humanities and Sociology, The University of Tokyo
Kaoruko Aita
PD3-4 R
oad map to year 2025 ~the 2nd national plan of cancer control measures and community
network of cancer terminal care
Health Management, Graduate School, International University of Health and Welfare
Masaki Muto
PD3-5 A
gendas to promote the guideline on the decision-making process of end-of-life care
Guidance of Medical Service Division, Health Policy Bureau,
Ministry of Health, Labour and Welfare
Masahiro Sasaki
47
August 29
PD3-1 A paradigm shift from palliative care to end-of-life care